Crowley Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25,371
Closed -$5.87M 4
2025
Q3
$5.87M Buy
25,371
+111
+0.4% +$22.6K 4.67% 4
2025
Q2
$4.69M Sell
25,260
-48
-0.2% -$8.92K 4.27% 8
2025
Q1
$5.3M Sell
25,308
-549
-2% -$107K 5.05% 2
2024
Q4
$4.59M Buy
+25,857
New +$4.75M 4.05% 5

Other funds holding ABBV

Crowley Wealth Management's ABBV Position: Q4 2025 in Review

Crowley Wealth Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 25,371 shares — an estimated $5.87M sold.

Crowley Wealth Management first reported a position in ABBV in Q4 2024 and held it in 4 quarters. The position peaked at $5.87M in Q3 2025. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Crowley Wealth Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Crowley Wealth Management sold 25,371 AbbVie shares in Q4 2025, an estimated $5.87M.
  • Crowley Wealth Management first reported a position in AbbVie in Q4 2024 and held it in 4 quarters.
  • Crowley Wealth Management's AbbVie position peaked at $5.87M in Q3 2025.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Crowley Wealth Management's 13F filing for Q4 2025.